| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 1113 | 2023 |
| Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population F Imtiaz, K Shafique, SS Mirza, Z Ayoob, P Vart, S Rao International archives of medicine 5 (1), 1-6, 2012 | 913 | 2012 |
| COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration LB Hilbrands, R Duivenvoorden, P Vart, CFM Franssen, MH Hemmelder, ... Nephrology Dialysis Transplantation 35 (11), 1973-1983, 2020 | 446 | 2020 |
| Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA ERACODA Working Group Duivenvoorden Raphaël Franssen Casper FM Hemmelder ... Nephrology Dialysis Transplantation 36 (1), 87-94, 2021 | 390 | 2021 |
| Effects of dapagliflozin in stage 4 chronic kidney disease GM Chertow, P Vart, N Jongs, RD Toto, JL Gorriz, FF Hou, JJV McMurray, ... Journal of the American Society of Nephrology 32 (9), 2352-2361, 2021 | 163 | 2021 |
| The RECOVAC immune-response study: the immunogenicity, tolerability, and safety of COVID-19 vaccination in patients with chronic kidney disease, on dialysis, or living with a … JSF Sanders, FJ Bemelman, AL Messchendorp, CC Baan, D van Baarle, ... Transplantation 106 (4), 821-834, 2022 | 159 | 2022 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 149 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 149 | 2024 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 119 | 2024 |
| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 117 | 2024 |
| Socioeconomic disparities in chronic kidney disease: a systematic review and meta-analysis P Vart, RT Gansevoort, MM Joosten, U Bültmann, SA Reijneveld American journal of preventive medicine 48 (5), 580-592, 2015 | 117 | 2015 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 111 | 2024 |
| Effect of face-to-face vs virtual reality training on cardiopulmonary resuscitation quality: a randomized clinical trial J Nas, J Thannhauser, P Vart, RJ van Geuns, HEC Muijsers, JQ Mol, ... JAMA cardiology 5 (3), 328-335, 2020 | 104 | 2020 |
| COVID-19-related mortality in kidney transplant and haemodialysis patients: a comparative, prospective registry-based study E Goffin, A Candellier, P Vart, M Noordzij, M Arnol, A Covic, P Lentini, ... Nephrology Dialysis Transplantation 36 (11), 2094-2105, 2021 | 93 | 2021 |
| Socioeconomic status and incidence of hospitalization with lower‐extremity peripheral artery disease: Atherosclerosis Risk in Communities study P Vart, J Coresh, L Kwak, SH Ballew, G Heiss, K Matsushita Journal of the American Heart Association 6 (8), e004995, 2017 | 93 | 2017 |
| National trends in the prevalence of chronic kidney disease among racial/ethnic and socioeconomic status groups, 1988-2016 P Vart, NR Powe, CE McCulloch, R Saran, BW Gillespie, S Saydah, ... JAMA network open 3 (7), e207932-e207932, 2020 | 84 | 2020 |
| Socioeconomic measures and CKD in the United States and The Netherlands P Vart, RT Gansevoort, J Coresh, SA Reijneveld, U Bültmann Clinical Journal of the American Society of Nephrology 8 (10), 1685-1693, 2013 | 79 | 2013 |
| Mediators of the Association between Low Socioeconomic Status and Chronic Kidney Disease in the United States P Vart, RT Gansevoort, DC Crews, SA Reijneveld, U Bültmann American Journal of Epidemiology 181 (6), 385-396, 2015 | 75 | 2015 |
| Efficacy and safety of dapagliflozin by baseline glycemic status: a prespecified analysis from the DAPA-CKD trial F Persson, P Rossing, P Vart, GM Chertow, FF Hou, N Jongs, ... Diabetes Care 44 (8), 1894-1897, 2021 | 73 | 2021 |
| Areca nut chewing and dependency syndrome: is the dependence comparable to smoking? A cross sectional study SS Mirza, K Shafique, P Vart, MI Arain Substance Abuse Treatment, Prevention, and Policy 6, 1-6, 2011 | 68 | 2011 |
